• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant

Valeant

Page 8 of 12
House Oversight Hearing On Prescription Drug Price Increases
FinanceWhy Valeant’s Stock Surged After CEO Admitted ‘Mistakes’
By Jen WiecznerFebruary 23, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
FinanceHere’s Why Valeant Shares Are Plunging Again
By ReutersFebruary 23, 2016
Views Of A CVS Caremark Corp. Store Ahead Of Earns
HealthCVS Just Made Valeant’s Day Even Worse
By Phil WahbaFebruary 22, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
FinanceHere’s Why Shares of Valeant Have Plunged for Their Second Straight Day
By ReutersFebruary 22, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Bought More Valeant
By Lucinda ShenFebruary 17, 2016
Squawk Box - Season 20
FinanceHere’s What Wall Street Thinks of Bill Ackman’s New Herbalife Attack
By Jen WiecznerFebruary 9, 2016
House Oversight Hearing On Prescription Drug Price Increases
HealthHow Martin Shkreli Is ‘Trashing’ the Pharma Industry
By Laura LorenzettiFebruary 4, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceBiotech Stocks Crashed and Nobody Knows Why
By Jen WiecznerJanuary 28, 2016
Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks at the Sohn Investment Conference in New York
FinanceBill Ackman to World: Not my Fault
By Jennifer ReingoldJanuary 28, 2016
valeant ceo michael pearson
LeadershipValeant’s CEO Isn’t Sure When He’ll Return from Medical Leave
By ReutersJanuary 25, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
HealthValeant Vows to Make Its Drugs ‘Affordable’
By Laura LorenzettiJanuary 13, 2016
HealthWalgreens Defends its Deal with Valeant
By Laura LorenzettiJanuary 7, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
HealthValeant Appoints Howard Schiller Interim CEO
By ReutersJanuary 6, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
LeadershipValeant Will Be Run by a Group of Executives Until Its CEO Returns
By ReutersDecember 28, 2015
VW Automobile Assembly
LeadershipThe 5 Biggest Corporate Scandals of 2015
By Chris Matthews and Stephen GandelDecember 27, 2015
1...
  • 6
  • 7
  • 8
  • 9
  • 10
...12
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents showAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartestAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Jerome Powell says you're right to blame data centers for making your bills more expensive: 'probably pushing inflation up'An image of a popular article
By Fortune EditorsMarch 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.